Axela Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Axela Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0141
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. The company creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products through a network of distributors in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Axela is headquartered in Toronto, Ontario, Canada.

Axela Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Axela Inc, Medical Equipment, Deal Details 10
Partnerships 10
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
Asset Transactions 16
ANGLE Acquires Assets from Axela 16
Acquisition 17
Axela Mulls Offering Itself For Sale 17
Axela Inc – Key Competitors 18
Axela Inc – Key Employees 19
Axela Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
Apr 10, 2017: Rapid blood test for intracranial hemorrhage in well appearing infants: a comprehensive brain injury study using Axela’s Flow-Thru Chip platform 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Axela Inc, Medical Equipment, Key Facts 2
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Deals By Market, 2012 to YTD 2018 8
Axela Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Scienion Enters into Co-Development Agreement with Axela 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Technology Integration Agreement With Hutman Diagnostics 12
Axela Enters Into Technology Integration Agreement With Thermal Gradient 13
Axela Enters Into Co-Marketing Agreement With OvaGene Oncology 14
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 15
ANGLE Acquires Assets from Axela 16
Axela Mulls Offering Itself For Sale 17
Axela Inc, Key Competitors 18
Axela Inc, Key Employees 19

List of Figures
Axela Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Axela Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Axela Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Axela Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Axela Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Axela Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務分析
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chiesi Farmaceutici SpA:企業の戦略的SWOT分析
    Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Elektrizitatswerk der Stadt Zurich:電力:M&Aディール及び事業提携情報
    Summary Elektrizitatswerk der Stadt Zurich (EWZ) is an alternative energy company that offers power and energy network services. The company’s services include power and energy supplying and distribution, contact and advice, fault messages, invoice and payment, online consulting and document center …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Damac Real Estate Development Ltd
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • JACCS Co., Ltd.:企業の戦略・SWOT・財務情報
    JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • National Oilwell Varco Inc (NOV):企業の財務・戦略的SWOT分析
    National Oilwell Varco Inc (NOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Vanda Pharmaceuticals Inc (VNDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Atrium Innovations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • Lukoil Oil Co (LKOH):石油・ガス:M&Aディール及び事業提携情報
    Summary Lukoil Oil Co (Lukoil) is a vertically integrated oil and gas company, which carries out exploration and production of crude oil and natural gas. Lukoil has interest in properties across Russia, Kazakhstan, Azerbaijan, Uzbekistan, the Middle East, South America, Northern and Western Africa a …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • CRH Plc (CRH):企業の財務・戦略的SWOT分析
    CRH Plc (CRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Elisa Oyj (ELISA):企業の財務・戦略的SWOT分析
    Elisa Oyj (ELISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆